The federal courts’ orders come at a time when some corporations and professional sports leagues are dealing with upticks in coronavirus cases.
In a statement released Friday night, the organization urged the Biden administration to delay the timeline of the implementation of the Emergency Temporary Standards. “We can work together to find visible ways to increase vaccination rates and mitigate the spread of the virus in 2022,” French said.cases spiking and the Omicron variant spreading across the country — and beyond U.S.
French’s statement noted that the NRF “has long maintained that OSHA, in promulgating it’s Vaccine Mandate Emergency Temporary Standard, exceeded the authority granted to it by Congress in 1970 and crafted a rule that is infeasible for employers to implement during the official holiday season.” The NRF is the largest global retail trade association. The retail sector is the largest private-sector employer in the U.S. and contributes $3.9 trillion to the annual gross domestic product.
The NRF’s stance was in response to the recent decision by the U.S. Court of Appeals for the Fifth Circuit to stay a nationwide mandate that had been put in place by the Western District Court of Louisiana at the end of last month. The district had banned the enforcement of the Centers for Medicare & Medicaid Services COVID-19 vaccine mandate among other things. The injunction allows the federal government to go forward with its efforts to implement the COVID-19 vaccine mandate in 24 states.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Raising rates would be a positive event for the U.S. economy, New York Fed's Williams says“Raising interest rates would be a sign of a positive development in terms of where we are in the economic cycle,” New York Fed President John Williams tells steveliesman.
Weiterlesen »
Qualification criteria changed for Winter OlympicsInternational Luge Federation changes qualification criteria for next year's Winter Olympics in Beijing to make sure athletes are not shortchanged
Weiterlesen »
Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Weiterlesen »
Low-dose Pfizer-BioNTech vaccine fails in trial on 2 to 5 year oldsA low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two through five years of age.
Weiterlesen »
Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Weiterlesen »
Pfizer to Test Third Dose of COVID Vaccine on Infants and Young Kids After Ineffective 2-Dose TrialThe two-dose vaccine regimen failed to give 2- to 5-year-olds a robust immune response.
Weiterlesen »